Skip to main content
FSCS logo

First Trust SMID Capital Strength ETF

FSCSNASDAQFirst TrustEquity

$37.16Today:- (-)1Y +2.61%

As of Oct 26, 2026 close

Assets (AUM)
$57.08M
Expense ratio
0.60%
Dividend yield
1.23%
Holdings
101
52-week range
$34.30$38.54
Volume (live)
-
Avg. volume (3M)
3.36K

FSCS ETF: First Trust SMID Capital Strength ETF - Price, Holdings & Analysis

First Trust SMID Capital Strength ETF Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Price & Trading Activity
Day's Range$37.16 - $37.39
52-Week High$38.54
52-Week Low$34.30
Open$37.39
Volume (last close)1.41K
Average Volume (3M)3.36K
Performance Metrics
1 Day Change+0.92%
1 Month Change+3.06%
6 Month Change+1.91%
YTD Change+4.15%
1 Year Change+2.61%
5 Year Change+24.40%
Dividend Information
Annual Dividend$0.46
Dividend Yield1.23%
Last Dividend Ex-DateSep 24, 2026
Dividend Growth YoY+68.17%
Fund Characteristics
Assets (AUM)$57.08M
Expense Ratio0.60%
Total Holdings101
Inception DateJun 19, 2017
Technical Indicators
50-Day MA$36.87
200-Day MA$36.56
RSI61.42
Stochastic %K94.65
Stochastic %D77.15

Source: Exchange price data and fund disclosures. Data as of Oct 26, 2026. Data sources and methodology

Compare FSCS with other ETFs

FSCS at a Glance

First Trust SMID Capital Strength ETF (FSCS) is an equity ETF from First Trust, launched in June 2017. It manages $57.08M in assets and charges a 0.60% expense ratio, about $60 a year per $10,000 invested.

As of its Oct 4, 2026 holdings, it holds 101 positions. The largest are MarketAxess Holdings Inc. (MKTX, 1.49%), Halozyme Therapeutics, Inc. (HALO, 1.46%) and IDT Corporation (IDT, 1.30%). The top 10 holdings make up 12.4% of the fund. By sector it leans toward Financials (28.9%), Industrials (26.7%) and Consumer Staples (13.5%). 94.0% of assets are in the United States.

It pays distributions yielding 1.23% at the Oct 26, 2026 close, $0.46 per share over the trailing 12 months. As of the Oct 26, 2026 close, the share price is up 2.6% over one year and up 24.4% over five years (price change, excluding distributions).

Frequently Asked Questions About First Trust SMID Capital Strength ETF

What is the current price of FSCS?

The latest FSCS price is $37.16 (Oct 26, 2026 close). The 52-week range is $34.30–$38.54. The share price is up 2.6% over the past year (price change, excluding distributions).

What is the expense ratio for FSCS?

FSCS's annual expense ratio is 0.60%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does FSCS pay dividends?

Yes, FSCS pays a 1.23% dividend yield (trailing 12 months, at the Oct 26, 2026 close). The most recent ex-dividend date was September 24, 2026. View full dividend history in the Dividends section.

What are the top holdings of FSCS?

As of Oct 4, 2026, FSCS's largest holdings are MarketAxess Holdings Inc. (1.5%), Halozyme Therapeutics, Inc. (1.5%), IDT Corporation (1.3%) (combined weight: 4.3%). The fund holds 101 total positions. View the complete portfolio breakdown in the Holdings section.

How does FSCS compare to similar ETFs?

Compare FSCS (0.60% expense ratio, $57M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.